Showing posts with label immune system. Show all posts
Showing posts with label immune system. Show all posts

Wednesday, November 19, 2014

Discovery of Human Immunodeficiency Viruses

The identification of HIV-1 as the causative agent of acquired immunodeficiency syndrome (AIDS) just 3 years after the clinical syndrome initially was described represents a remarkable scientific achievement that had its roots in earlier discoveries of animal and human retroviruses. The selective loss of CD4+ helper T lymphocytes in patients with the disease implicated an agent with T-lymphocyte cell tropism. As expected for an etiologic agent, HIV-1 was shown to be uniformly present in subjects with AIDS and to reproduce the hallmark of disease, destruction of T lymphocytes, in tissue culture.

General Biologic Properties of HIV-1:

Soon after its discovery, HIV-1 was shown to be biologically, structurally, and genetically distinct from human T-lymphotrophic virus I (HTLV-I) and HTLV-II and more like members of the lentivirus subfamily of retroviruses.

Unlike the leukemia viruses, which lead to immortalization of lymphocytes in vitro and in vivo, HIV-1 exhibits pronounced cytopathic properties for lymphocytes, causing syncytia formation and cell death. Morphologically, HIV-1 differs from HTLV-I and other type C oncogenic retroviruses in exhibiting a dense, cylindrical core surrounded by a lipid envelope typical of lentiviruses.

Like all retroviruses, HIV-1 is a single-stranded plus-sense RNA virus. The RNA-dependent DNA polymerase, or reverse transcriptase, is packaged within the virion core and is responsible for replicating the single-stranded RNA genome through a double-stranded DNA intermediate, which in turn serves as the precursor molecule for proviral integration within the host cell genome. The major structural core proteins of HIV-1 are the p24 capsid protein and the p18 matrix protein, as shown. Surrounding the viral core protein structures is a bilayered lipid envelope that is derived from the outer limiting membrane of the host cell as the virus buds from the cell surface during replication. Studding this outer viral membrane are the envelope glycoproteins, gp120 and gp41, which are encoded by viral-specific genes and are responsible for cell attachment and entry.

Features of this life cycle distinguish retroviruses from all other viruses. The cell-free virion first attaches to the target cell through a specific interaction between the viral envelope and the host cell membrane. The specificity of this interaction between virus and cell has been shown to be due to a high-affinity specific interaction between the viral gp120 envelope glycoprotein and the target cell-associated CD4 molecule. Following virus adsorption, the viral and cellular membranes fuse, resulting in internalization of the nucleoprotein viral complex. Reverse transcription catalyzed by the viral reverse transcriptase generates a double-stranded DNA copy of the viral RNA within the nucleoprotein complex, and this migrates to the nucleus where covalent integration of viral DNA into the host chromosomes leads to formation of the provirus. Subsequent expression of viral DNA is controlled by a combination of viral and host cellular proteins that interact with viral DNA and RNA regulatory elements.

Transcribed viral mRNA is translated into viral proteins, and new virions are assembled at the cell surface where genomic-length viral RNA, reverse transcription, structural and regulatory proteins, and envelope glycoproteins are assembled. Because the HIV-1 pro-virus is covalently integrated within the host cell chromosome, it represents a stable component of the host genome and is replicated and transmitted to daughter cells in synchrony with cellular DNA. Relevant to subsequent discussions of viral pathogenesis, the integrated provirus is thus permanently incorporated into the host cell genome and may remain transcription ally latent or may exhibit high levels of gene expression with explosive production of progeny virus.

Wednesday, November 12, 2014

HIV Positive - This Bodybuilder is Positive about Life

As Schwarzenegger wannabes pit muscle against muscle to win India’s top bodybuilding prize, among these combatants will be one individual who is competing against life itself. This is an inspiring story of the can-do spirit. He is HIV+ but he is also positive about life. If you meet Khundrakpam Pradipkumar Singh you might feel a tinge of sympathy about a man who might soon come to the end of the road. But for Khundrakpam the journey is just beginning. Even today there might not be a cure for the dreaded virus but this inspiring individual busts the myth that HIV+ means a date with mortality and despair. Pradipkumar, tested positive for HIV seven years ago. Today, seven years down the line he is a bodybuilder and one of the contenders for the Mr. India title. "I was into drugs and that is how I contracted the virus. There was pain, anguish and a deep sense of guilt. That is when I decided to channelize all my emotions into body building and maintaining a fitness level."He began bodybuilding in 2003 and along with retroviral therapy he turned to the gym. He won the state title in the 60kg category. Medals and title came his way and soon he was competing at the national level. A runner-up at the Senior Mr. India Challenge Cup provided him further motivation to look at the bigger horizon. For the ultimate national title in the sport, he has had to mortgage his sister’s gold jewelry to make the trip to Kolkata.
Khundrakpam summarizes his gung-ho spirit by saying,"I want to prove that HIV is not the end of the world. I want to be a role model for such patients and tell the world that WE CAN."His motivational journey has been recognized by his state government which made him the face of their AIDS campaigns as a brand ambassador. Despite being a household name in his state of Manipur, financial help has been difficult to come by. Though that has hindered his diet and preparations, it hasn’t blocked his vision and attitude.
Even as he has his sights set on winning the national crown he dreams of contributing to society one day.

Things about HIV/AIDS you didn’t know:

2.3 million people were HIV positive in India. The disease was found to be most prevalent in southern and northern states with Andra Pradesh and Manipur having the highest number of cases. HIV was more prevalent men than in women and was seen in people between 15-49 years of age. The good news here is that the survey found that the number of people infected with HIV has decreased by 50% in 2011. This World AIDS day, the theme is ‘Getting to Zero’ – zero new HIV infections, zero discrimination and zero AIDS-related deaths. So in order to help us all move towards that goal here are eleven things about HIV/AIDS that you might not have known. HIV stands for Human Immunodeficiency Virus. A person is termed to be HIV positive when they are found to be infected by this virus. As the disease progresses it eventually eats away at the immune system of the patient, causing a number of opportunistic infections to take hold along the way.  AIDS or Acquired Immunodeficiency Disease is a host of conditions that are associated with the loss of one’s immune system – according to the CDC when a person’s CD4 count is below 200 cells/mm3.  This is the most severe stage of the infection. HIV and AIDS are different and a person who is HIV positive does not necessarily have AIDS.

You probably knew that HIV originated in monkeys. But did you know that there are actually two types of HIV strains? Labeled as HIV 1 and HIV 2, these two strains have been found in chimpanzees and small African monkeys. HIV 1 is the more potent of the two strains and is what most commonly causes HIV infection.

Once a person is infected with HIV it takes at least 10 years for it to progress into AIDS. AIDS is the final or most severe stage of the disease when the immune system of the patient’s body has been compromised greatly. 

The symptoms of HIV/AIDS very often mimic the symptoms of other very common diseases like the common cold or flu. While a person infected with the virus may experience symptoms within 2-3 weeks of being infected it may take up to three months. There are also some people who may be absolutely asymptomatic. The common symptoms of the condition are fever, rash, chills, sore throat, rash, night sweats, fatigue, swollen lymph nodes, muscle aches and ulcers in the mouth.

The test for HIV involves either testing your blood or your saliva for the presence of the antigen against HIV. The problem with this test was that it could not pick up the presence of the antigen you a patient’s body until he/she started producing antibodies to the virus, which usually takes about 12 weeks.  Recently a new test has been devised that tests for the presence of antibodies against the virus. This is far more accurate and one can get the test done as soon as they think they have been infected. All you have to do is go to a nearby testing center and check if you have been infected by giving a simple blood test. The test is not painful and is completed in about 10 minutes. Many people believe that if an HIV positive person cooks for them or somehow their blood is ingested they can contract the disease. This is not possible, because the HIV virus – for all the havoc it creates in our body – is extremely fragile and cannot survive outside a host. More importantly it is essential that blood containing the virus enter a person’s blood stream, this requires a deep injection directly into the blood vessels. Another fact to consider is the HIV virus cannot stand excessive heat. Even the heat generated by the sun damages it, so if one were to bleed into your food and cook it, you are highly unlikely to contract HIV. And finally everybody has a mucosal lining on the inside of our mouth and nose. So when we eat the HIV virus will not be able to infect a person.

Wednesday, September 17, 2014

Risk of invasive pneumococcal disease remains high for people living with HIV

The risk of cancer is increased twofold for people with HIV compared to individuals in the general population, Danish investigators report in the online edition of AIDS. But the increased risk was almost entirely due to higher incidence of smoking-related cancers and also malignancies caused by viral infections. The risk of other cancers did not differ between the people with HIV and people who did not have HIV.

“In the present study we found that the increased risk of non-AIDS cancer was largely confined to cancers associated with smoking and viral infections,” write the authors. “The risk of cancers that are not considered strongly related to smoking or viral infections did not differ between the HIV-infected and the background population, and the impact of immune deficiency was limited.”

Non-AIDS-related cancers are an increasingly important cause of serious illness and death among people with HIV. The exact causes are uncertain. However, possible explanations include high rates of smoking, a high burden of viral co-infections such as hepatitis C virus (HCV) and human papillomavirus and immune suppression caused by HIV.

Investigators from Denmark wanted to establish the proportions of cancers in people living with HIV attributable to smoking, viral infections, and HIV-related immune suppression.

They therefore compared the incidence of cancer between people with HIV and matched controls in the general population. Results were stratified according to smoking status and immune deficiency. Cancers were categorised as smoking-related, virus-related or 'other'.

The HIV-positive population consisted of 3503 individuals who received care between 1995 and 2011. Their average CD4 count at baseline was 450 cells/mm3. At the time of inclusion in the study, 77% were taking HIV therapy and, for 92% of follow-up time, the people with HIV were taking antiretroviral therapy.

The control population consisted of 12,979 individuals. There were 157 cancer diagnoses among the people living with HIV compared to 255 diagnoses among the controls. The overall incidence of cancer was twice as high in people with HIV compared to the controls (IRR = 2.0; 95% CI, 1.6-2.5).

The incidence of cancers related to viral infections was almost twelvefold higher in the HIV-positive population than in the HIV-negative controls (IRR = 11.5; 95% CI, 6.5-20.5). Incidence of smoking-related cancers was almost threefold higher among people with HIV (IRR = 2.8; 95% CI, 1.6-4.9). The risk of other cancers did not differ between the people living with HIV and the HIV-negative controls.

Incidence of smoking-related cancers associated with current smoking was significantly higher among the people living with HIV (IRR = 21.35; 95% CI, 2.88-158.5) than the controls (IRR = 4.12; 95% CI, 1.74-9.78). For the people with HIV, a lowest-ever (nadir) CD4 count below 200 cells/mm3 was associated with a more than threefold increase in the risk of lung cancer (IRR = 3.54; 95% CI, 1.00-12.59). No patients with a nadir CD4 count above 200 cells/mm3 developed a smoking-related cancer.

Smoking-related and virus-associated malignancies accounted for 23% and 43% of cancers diagnosed in the HIV-positive population. Virological cancers were rare in the controls. The fractions of all cancers in the HIV-positive population attributable to smoking and viral infections were 27% and 49%, respectively.

For cancer types considered associated with smoking, the proportion attributed to smoking was 91%. The proportion of virus-related cancers attributed to having HIV was also 91%.

For cancers not strongly related to smoking or viral infections, the proportion attributable to being HIV positive and immune deficiency were 0%.

Tuesday, September 9, 2014

Deca Durabolin highly effective drug

Deca Durabolin has an active life of 14-16 days and is detectable over a period of 16-18 months. Belonging to the category of anabolic-androgenic steroids and classified as a 2.16 anabolic steroid, Deca is a highly effective drug that is available in different forms such as creams, pills, capsules and gels. Medically, the drug is advised to stimulate immune system enhancements and offer dramatic relief to HIV/AIDS patients and even treat specific blood disorders as part of the adjuvant therapy. This steroid is used by sportsmen to benefit from the improved recuperation time between workouts, protein synthesis, and nitrogen retention. Nandrolone is the base hormone, but it is better known under the trade name Deca Durabolin, which contains Nandrolone Decanoate. This popular preparation takes the Nandrolone hormone and adds a Decanoate ester chain. This ester chain is attached during the manufacturing process and it serves dual purposes. The main purpose is to make the hormone oil soluble, so it can be put in an amp or multi-dose vial. The second purpose of this ester chain is to slow-release the steroid by keeping deca from interacting with androgen receptors until the ester chain is cleaved off by enzymes in your body. Since Nandrolone Necanoate cannot attach to an androgen receptor until enzymes in your body have cleaved off the Decanoate ester, it causes the steroid to slow-release into your system over many days. For medical use, the ester’s main function is to allow the hormone to be injected only once every 3 weeks. However, bodybuilders may inject Deca Durabolin weekly or as often as every three days.

Moreover, this steroid is admired as its use even for long anabolic steroid cycles does not result in side effects like oily skin, male pattern baldness, and prostate complications. If that was not all, Deca use is considered of great use to mask minor joint pain and old nagging injuries besides reducing the inflammation of soft tissues and promoting masculine (secondary sexual) characteristics, including growth of the vocal cords, testicles, and body hair. This steroid is commonly used in doses of 300-800 mg per week by men and 50-100 mg per week by women or in doses of 600 mg per week for 12-16 weeks by men for bulking cycles and 400 mg per week for 12-16 weeks by men in cutting cycles.

A popular Deca Durabolin cycle is all about using Dianabol-30 mg every day for week 1-3 and then 40 mg every day for week 4-6 and complementing it with Sustanon 250 mg every week for week 1-12, Clomid 50 mg every week for week 10-12, and Deca Durabolin-200 mg for the first week and then 300 mg per week for 2nd and 3rd weeks, and 400 mg every week for 4th and 5th weeks, and 300 mg every week for the sixth week. Overdosing or use of low grade or abuse of Deca Durabolin can lead to side effects such as may even cause heart attack, edema, prostate enlargement, menstrual problems, liver toxicity, liver damage, and gynecomastia (female-like breasts). It may even cause elevated blood pressure, shrinking of the testicles, bone age advancement, bad effect on cholesterol levels, increased aggression, oily skin, acne, clitoral hypertrophy, infertility, and sexual dysfunction.

Side Effects:   
Side effects with Deca are much less than other steroids such as straight testosterones.  In fact, people choose Deca for this reason.  It’s not toxic to the liver and not particularly toxic to other organs of the body, and it’s highly effective.  That makes for a potent muscle-building brew; one you can really sink your teeth into without the threat of a lot of consequence.  It’s not, however, totally without them. Knowing how vain most bodybuilders truly are, most are thrilled that Deca doesn’t have acne as a side-effect.  In rare cases, there will be slight breakout, but not among the majority.  Now, that’s when you take 400mg/week.  But like anything worth doing, Deca is worth overdoing.  Right in the neighborhood of 600-1000mg/week is what I’m talking about.  This is where side effects begin to emerge and where you need to be aware of what they are.  Attitude can get hostile, sex drive can be out of control, sperm production can be non-existent (with prolonged use) and headaches can prevail. Also, the more you take, the more water you’ll have just beneath the skin to smooth out your appearance.  It really depends upon how vain you are. 

Wednesday, August 27, 2014

Effects of nutrition on HIV Disease progression

The links between HIV and nutritional status run both ways. It has long been known that weight loss strongly predicts illness or death among people with HIV. More recently it has been found that this applies even to people taking antiretroviral treatment. Losing as little as 3-5% of body weight significantly increases the risk of death, losing more than 10% is associated with a four- to six-fold greater risk. A Zambian study involving nearly 30,000 patients has shown that failure to gain weight six months after the start of antiretroviral treatment increases the chance of death ten fold when compared with those who gain over 10 kilograms.

Various micro nutrients have been linked to changes in the rate at which HIV infection progresses to AIDS. Low levels of vitamin A, vitamin B12, vitamin E and selenium seem to accelerate progression. The effects of other micro nutrients, however, are more controversial. One such example is zinc. Although zinc is essential for a healthy immune system, it has been shown to play a role in HIV’s replication cycle. 12 On the other hand, some scientists claim zinc delays HIV disease progression.
There is strong evidence that malnourished people are less likely to benefit from antiretroviral treatment. One study in Malawi found that patients with mild malnutrition (a low body weight for their height) were twice as likely to die in the first three months of treatment. For those with severe malnutrition the risk was six times greater than for those of healthy body weight. Researchers in Singapore have reported similar findings. A study in Zambia showed death rates in the first three months of starting antiretroviral treatment were highest (95%) among the most severely malnourished. This is not just an issue for developing countries for example a study of people receiving antiretroviral treatment in Sydney, Australia found that one in three did not have access to nutritious food, and one in five said they regularly went hungry.

Without food or the right nutrition, taking antiretroviral drugs can be so painful that people simply don’t. In a choice between taking pills with no immediate or obvious effect, and eating food to survive, food will almost certainly take priority every time. A health worker in Zimbabwe, where malnutrition is widespread, explained that taking antiretroviral drugs on an empty stomach is like digesting razor blades. The result is that many simply do not take them. In resource-poor countries, treatment in children is made more difficult because many children with HIV are severely malnourished. Very little is known about how best to treat such children and in particular whether it is best to start antiretroviral treatment before or after nutritional rehabilitation. The World Health Organisation recommends treating the malnutrition first, but stresses that “further research on these matters is urgently needed.”

The ways in which the body digests, absorbs and makes use of drugs are very similar to the ways in which it treats food, providing many opportunities for food-drug interactions. As explained later in this article, a number of foods and supplements are known to alter the effects of antiretroviral drugs. It is also possible that some micro nutrient deficiencies may make the drugs less effective, or may worsen side effects.
The chance of someone transmitting HIV is linked to the amount of virus in their bodily fluids, which is known as the viral load. In theory, micro nutrient deficiencies may increase viral load by enabling HIV to replicate faster, or by weakening the immune system. Similarly, someone whose immune system has been weakened by micro nutrient deficiencies may be more likely to acquire HIV. Research in this area has, however, been largely inconclusive. The strongest evidence links low levels of retinol (the animal form of vitamin A) in women’s blood with increased rates of mother-to-child transmission.

Poor nutrition may also affect the spread of HIV in a very different way: by altering sexual behavior. One study of two thousand people in Botswana and Swaziland found that women lacking enough food to eat were less likely to use condoms and more likely to engage in risky activities, such as exchanging sex for money or resources.

Dietary advice should be tailored to individual circumstances. However, in general the recommendations for people living with asymptomatic HIV infection are much the same as for everyone else, meaning a healthy, balanced diet. Only three differences are worth noting:

- Because people with untreated HIV tend to burn more energy, the total number of calories should be around 10% higher than the usual guideline amounts, and up to 30% higher during recovery from illness. The balance of fat, protein and carbohydrates should remain the same.
- Many experts recommend a daily multivitamin (usually without iron, except in menstruating women or people with iron deficiency).
- The World Health Organisation recommends vitamin A supplements every 4-6 months for young children living with HIV in resource-poor settings.

HIV positive people suffering loss of appetite may need to make an extra effort to ensure they are eating enough. Helpful suggestions include eating several small meals per day, taking exercise to stimulate appetite, possibly mashing or liquidizing food to ease swallowing, and seeking advice from a health provider or dietician.

If other approaches have failed to reverse wasting then doctors may recommend a liquid food supplement, an appetite stimulant, or resistance exercise to build muscle. Other possibilities include steroids and hormone treatments, though these can be expensive and have serious side effects.

Tuesday, July 15, 2014

HIV-1 and immune system

Of the two major types of HIV, only one, HIV-1, typically causes AIDS in infected people who don't receive treatment. A study published by Cell Press November 21st in the journal Immunity reveals how HIV-1 escapes detection by essentially becoming invisible to a patient's immune system, whereas HIV-2 triggers protective immune responses in patients. This understanding of how HIV-1's "invisibility cloak" works could lead to the development of effective vaccines against HIV-1.

"Our study shows for the first time exactly how immune cells sense the virus and how the virus uses one of its proteins to tune its stealthiness and infectivity," says senior study author Nicolas Manel of the Institut Curie. "We also show how to modify the virus so that it is properly recognized and leads to a beneficial immune response."

Individuals who are infected with both HIV-1 and HIV-2 do better than those infected with HIV-1 alone, suggesting that the immune response against HIV-2 protects against the effects of HIV-1 infection. While searching for an explanation in previous studies, Manel and his collaborators found that HIV-2, but not HIV-1, naturally infects and activates dendritic cells, which play a major role in triggering protective immune responses. But until now, it was not known how HIV is detected in dendritic cells.

In the new study, Manel and his team focused on the capsid—the protein shell of a virus that encloses its genetic material. By mutating HIV-1 and HIV-2 capsids, they discovered that these viral proteins control the ability of dendritic cells to sense the viruses and activate immune responses.

The researchers found that the HIV-1 capsid allows the virus to escape detection by dendritic cells under normal conditions. But when they mutated the HIV-1 and HIV-2 capsids, the dendritic cells produced immune responses without getting infected by the viruses. These cells relied on a protein called cyclic GMP-AMP synthase (cGAS) to sense the viral DNA in the cytosol before the foreign DNA became integrated into the host genome.

These findings open new avenues for the development of effective treatments against HIV-1. "By modifying the capsid of a virus, we could engineer a virus that is both better recognized by the immune system and that has also lost its ability to infect cells," Manel says. "Beyond capsid-mutated viruses, our results suggest that activating the cGAS pathway in dendritic cells could induce immunity against HIV-1.

Tuesday, June 24, 2014

HIV and nutrition are intimately linked

HIV infection can lead to malnutrition, while poor diet can in turn speed the infection’s progress. As HIV treatment becomes increasingly available in the poorest parts of the world, critical questions are emerging about how well the drugs work in people if they are short of food. Uncertainty also surrounds the role of vitamins and other supplements. And for those already receiving treatment, side effects such as body fat changes are a daily concern.

Understandably, HIV positive people and those who care for them are interested in whatever might benefit their health. This article looks at what is known about the relationships between HIV and nutrition.  HIV and AIDS is well known for causing severe weight loss known as wasting. In Africa, the illness was at first called “slim” because sufferers became like skeletons. Yet body changes are not only seen during AIDS less dramatic changes often occur in earlier stages of HIV infection. Whereas starving people tend to lose fat first, the weight lost during HIV infection tends to be in the form of lean tissue, such as muscle. This means there may be changes in the makeup of the body even if the overall weight stays the same.

In children, HIV is frequently linked to growth failure. One large European study found that children with HIV were on average around 7 kg (15 lbs) lighter and 7.5 cm (3 inches) shorter than uninfected children at ten years old. One factor behind HIV-related weight loss is increased energy expenditure. Though no one knows quite why, many studies have found that people with HIV tend to burn around 10% more calories while resting, compared to those who are uninfected. People with advanced infection or AIDS (particularly children) may expend far more energy.

But faster metabolism is not the only problem. In normal circumstances, a small rise in energy expenditure may be offset by eating slightly more food 4 or taking less exercise. There are two other important reasons why people with HIV may lose weight or suffer childhood growth failure.

The first factor is decreased energy intake or, to put it simply, eating less food. Once HIV has weakened the immune system, various infections can take hold, some of which can affect appetite and ability to eat. For example, sores in the mouth or throat may cause pain when swallowing, while diarrhea or nausea may disturb normal eating patterns. Someone who is ill may be less able to earn money, shop for food or prepare meals. Stress and psychological issues may also contribute.

Secondly, weight loss or growth failure can occur when the body is less able to absorb nutrients – particularly fat – from food, because HIV or another infection (such as cryptosporidium) has damaged the lining of the gut. Diarrhea is a common symptom of such malabsorption. Micronutrients are vitamins and minerals that the body needs to maintain good health. Researchers have found that people with HIV are more likely to show signs of micro nutrient deficiencies, compared to uninfected people. Specifically they have found low levels of vitamin A, vitamin B12, vitamin C, vitamin D, carotids, selenium, zinc and iron in the blood of various populations.

Nevertheless, it must be noted that the evidence is not entirely conclusive. It is possible that HIV might affect the markers used to measure micro nutrient levels more than it affects the actual amounts of micro-nutrients available in the body.  Some studies suggest that antiviral treatment improves micro nutrient status.

Friday, February 28, 2014

Genital Herpes Natural Remedies

There have been tests carried out to see if there are any normal remedies that can help and some results have been quite promising. It has been a case that some items work for some people and yet do nothing to help others. It will be best to try a few different ones and see what works for you. Echinacea has been tested on a little number of people and there was no lessening of outbreaks between the times when they took the result and when they took a placebo. What does not seem to have been recorded is if the symptoms were eased in any way. Propolis has also been tried. This is a waxy substance that bees make and again it was not intended as a cure but meant to help the sores heal more rapidly. There was a significant distinction in the time that the sores healed if propolis was used then when the patient was treated with other products.
Ice has been considered a good way to take away some of the enlargement and irritation. There are going to be times in the winter when this is not possible and then the different could be a cool or just warm bath with baking soda added. Taking supplements will be significant in trying to calm down the irritation and zinc is considered to be one of the better ones to use. Vitamin C has long been proven to raise the immune system and help you feel better and while this virus is worse than a cold there will still be some degree of benefit. Vitamin B12 works by providing vitamins to the body to help meet nutritional requirements. Tea tree oil is a natural antiseptic and so it will be safe to use this and know that there will not be any further damage. This should just be dabbed on and allowed to soak in. It can be reapplied as and when needed. Nutriment can be an significant ingredient over the days that you have an outbreak. Foods that contain arginine can cause additional difficulty and this is originate in nuts, meat and dairy products. This will make your meals quite compressed to put together but if there is an betterment in your demand it will be worth it.